Clinical Hospital Colentina
15
1
3
9
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 15 trials
100.0%
+13.5% vs industry average
13%
2 trials in Phase 3/4
0%
0 of 9 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (15)
Assessment of the Role of Incisura Biopsy in the Staging of Chronic Gastritis
Role: lead
Impact of Positive Bile Cultures on Plastic Biliary Stent Exchange
Role: lead
Gastric CLEANsing by Intravenous AZithromycin in Urgent Endoscopy
Role: lead
Evaluation of Cardiac Function in Acutely Decompensated Cirrhosis
Role: lead
Endoscopy and Radiology-guided Ablation for Inoperable Cholangiocarcinoma
Role: lead
Trainee Involvement in ERCP Risk Score
Role: lead
EUS vs. MDCT in Pancreatic Malignancy
Role: lead
EUS Evaluation of CBD Diameter in Malignant Obstructive Jaundice
Role: lead
Quality Assessment in Endoscopic Retrograde Cholangiopancreatography(ERCP)
Role: lead
Multimodal Approach in IBD Patients
Role: lead
Individualized Bowel Preparation for Colonoscopy
Role: lead
A Multicenter Single-blind Comparison Between Standard and Individualized Approach in Bowel Preparation Before Colonoscopy
Role: lead
Difficult Colon Polypectomies
Role: lead
Comparison of Preparation Regimens for Colonoscopy
Role: lead
The Characterization of Small Bowel and Colonic Involvement in Patients With Seronegative Spondyloarthritides
Role: collaborator
All 15 trials loaded